Correlation Between Akero Therapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Akero Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Sana Biotechnology.
Diversification Opportunities for Akero Therapeutics and Sana Biotechnology
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akero and Sana is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Sana Biotechnology
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.83 times more return on investment than Sana Biotechnology. However, Akero Therapeutics is 1.2 times less risky than Sana Biotechnology. It trades about 0.02 of its potential returns per unit of risk. Sana Biotechnology is currently generating about 0.01 per unit of risk. If you would invest 4,216 in Akero Therapeutics on August 28, 2024 and sell it today you would lose (1,039) from holding Akero Therapeutics or give up 24.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Sana Biotechnology
Performance |
| Timeline |
| Akero Therapeutics |
| Sana Biotechnology |
Akero Therapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Sana Biotechnology
The main advantage of trading using opposite Akero Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |